520 related articles for article (PubMed ID: 19057660)
21. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
22. Accessibility and contribution to glucan masking of natural and genetically tagged versions of yeast wall protein 1 of Candida albicans.
Granger BL
PLoS One; 2018; 13(1):e0191194. PubMed ID: 29329339
[TBL] [Abstract][Full Text] [Related]
23. Nature of β-1,3-Glucan-Exposing Features on Candida albicans Cell Wall and Their Modulation.
de Assis LJ; Bain JM; Liddle C; Leaves I; Hacker C; Peres da Silva R; Yuecel R; Bebes A; Stead D; Childers DS; Pradhan A; Mackenzie K; Lagree K; Larcombe DE; Ma Q; Avelar GM; Netea MG; Erwig LP; Mitchell AP; Brown GD; Gow NAR; Brown AJP
mBio; 2022 Dec; 13(6):e0260522. PubMed ID: 36218369
[TBL] [Abstract][Full Text] [Related]
24. Pga26 mediates filamentation and biofilm formation and is required for virulence in Candida albicans.
Laforet L; Moreno I; Sánchez-Fresneda R; Martínez-Esparza M; Martínez JP; Argüelles JC; de Groot PW; Valentín-Gomez E
FEMS Yeast Res; 2011 Aug; 11(5):389-97. PubMed ID: 21439008
[TBL] [Abstract][Full Text] [Related]
25. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.
Chen YL; Lehman VN; Averette AF; Perfect JR; Heitman J
PLoS One; 2013; 8(3):e57672. PubMed ID: 23472097
[TBL] [Abstract][Full Text] [Related]
26. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
27. Candida albicans hypha formation and mannan masking of β-glucan inhibit macrophage phagosome maturation.
Bain JM; Louw J; Lewis LE; Okai B; Walls CA; Ballou ER; Walker LA; Reid D; Munro CA; Brown AJ; Brown GD; Gow NA; Erwig LP
mBio; 2014 Dec; 5(6):e01874. PubMed ID: 25467440
[TBL] [Abstract][Full Text] [Related]
28. Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p.
Pendrak ML; Rodrigues RG; Roberts DD
Med Mycol; 2007 Mar; 45(2):157-68. PubMed ID: 17365652
[TBL] [Abstract][Full Text] [Related]
29. Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.
Badrane H; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3591-600. PubMed ID: 27021331
[TBL] [Abstract][Full Text] [Related]
30. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA
Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
[TBL] [Abstract][Full Text] [Related]
31. A computational model for regulation of nanoscale glucan exposure in Candida albicans.
Wester MJ; Lin J; Neumann AK
PLoS One; 2017; 12(12):e0188599. PubMed ID: 29232689
[TBL] [Abstract][Full Text] [Related]
32. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
mBio; 2016 May; 7(3):. PubMed ID: 27165800
[TBL] [Abstract][Full Text] [Related]
33. Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.
MacCallum DM; Desbois AP; Coote PJ
Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1055-62. PubMed ID: 23572153
[TBL] [Abstract][Full Text] [Related]
34. Identification of 10 genes on
Sah SK; Yadav A; Kruppa MD; Rustchenko E
Microbiol Spectr; 2023 Dec; 11(6):e0329523. PubMed ID: 37966256
[No Abstract] [Full Text] [Related]
35. Activation and alliance of regulatory pathways in C. albicans during mammalian infection.
Xu W; Solis NV; Ehrlich RL; Woolford CA; Filler SG; Mitchell AP
PLoS Biol; 2015 Feb; 13(2):e1002076. PubMed ID: 25693184
[TBL] [Abstract][Full Text] [Related]
36. The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Wiederhold NP; Najvar LK; Fothergill AW; McCarthy DI; Bocanegra R; Olivo M; Kirkpatrick WR; Everson MP; Duncanson FP; Patterson TF
Antimicrob Agents Chemother; 2015 Jan; 59(1):690-2. PubMed ID: 25331706
[TBL] [Abstract][Full Text] [Related]
37. Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.
Hoehamer CF; Cummings ED; Hilliard GM; Rogers PD
Antimicrob Agents Chemother; 2010 May; 54(5):1655-64. PubMed ID: 20145080
[TBL] [Abstract][Full Text] [Related]
38. Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans.
Wagner AS; Lumsdaine SW; Mangrum MM; King AE; Hancock TJ; Sparer TE; Reynolds TB
PLoS Genet; 2022 Sep; 18(9):e1010405. PubMed ID: 36121853
[TBL] [Abstract][Full Text] [Related]
39. Candida albicans beta-glucan exposure is controlled by the fungal CEK1-mediated mitogen-activated protein kinase pathway that modulates immune responses triggered through dectin-1.
Galán-Díez M; Arana DM; Serrano-Gómez D; Kremer L; Casasnovas JM; Ortega M; Cuesta-Domínguez A; Corbí AL; Pla J; Fernández-Ruiz E
Infect Immun; 2010 Apr; 78(4):1426-36. PubMed ID: 20100861
[TBL] [Abstract][Full Text] [Related]
40. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
